Linagliptin approved for type 2 diabetes

被引：0
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2011年 / 68卷 / 12期
关键词：
D O I：
10.2146/news110038
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 50 条
  • [41] Linagliptin and Glimepiride Equally Effective for Adults with Type 2 Diabetes Mellitus
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (05) : 309 - 310
  • [42] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [43] Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
    Shigiyama, Fumika
    Kumashiro, Naoki
    Miyagi, Masahiko
    Iga, Ryo
    Kobayashi, Yuka
    Kanda, Eiichiro
    Uchino, Hiroshi
    Hirose, Takahisa
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (03) : 330 - 340
  • [44] Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment
    Sloan, Lance
    Newman, Jennifer
    Sauce, Christophe
    Von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A114 - A114
  • [45] Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus
    Yu. S. Gavrilova
    N. P. Bgatova
    V. V. Klimontov
    I. Yu. Ischenko
    S. V. Michurina
    N. E. Myakina
    E. L. Zavyalov
    Bulletin of Experimental Biology and Medicine, 2016, 161 : 501 - 504
  • [46] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A158 - A158
  • [47] Efficacy and Safety of Linagliptin in Patients with Type 2 Diabetes and Poor Glycemic Control
    Del Prato, Stefano
    Taskinen, Marja-Riitta
    Owens, David
    Von Eynatten, Maximillian
    Emser, Angela
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A293 - A293
  • [48] Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
    Gallwitz, Baptist
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 1 - 9
  • [49] Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus
    Triplitt, C.
    Solis-Herrera, C.
    Cersosimo, E.
    Abdul-Ghani, M.
    Defronzo, Ralph A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) : 2819 - 2833
  • [50] Erratum to: Linagliptin: a review of its use in the management of type 2 diabetes mellitus
    Emma D. Deeks
    Drugs, 2013, 73 : 99 - 99
12345